SCHEMBL2120339

SCHEMBL2120339

COC(=O)c1c(C(C)=O)ccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 2/20 0.56
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RCE1 Q9Y256 1/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL71131 0.90 NCEH1 (0.59) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL29404644 0.90 NCEH1 (0.59) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL1667159 0.87 NCEH1 (0.56) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL975681 0.84 NCEH1 (0.53) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL11055931 0.84 NCEH1 (0.54) NCEH1MEN1KMT2AMAPTALDH1A1
Hexane SCHEMBL28059901 0.83 NCEH1 (0.52) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL27553166 0.83 CDC25B (0.55) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL27723137 0.82 ALDH1A1 (0.49) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL3678050 0.82 NCEH1 (0.51) NCEH1MEN1KMT2AMAPTALDH1A1
SCHEMBL2120169 0.81 PTPN1 (0.55) NCEH1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444401-B1 NOVEL IMIDAZOPYRIDINE COMPOUND ONO PHARMACEUTICAL CO (JP) 2014-09-03 EP disclosed
US-8569504-B2 Imidazopyridine compound ONO PHARMACEUTICAL CO., LTD. (JP) 2013-10-29 US disclosed
EP-2444401-A1 NOVEL IMIDAZOPYRIDINE COMPOUND ONO Pharmaceutical Co., Ltd. (JP) 2012-04-25 EP disclosed
US-20120094944-A1 NOVEL IMIDAZOPYRIDINE COMPOUND ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094944-A1 NOVEL IMIDAZOPYRIDINE COMPOUND CMA1, ACE, ALPI NCEH1 22/4885MEN1 2671/4885KMT2A 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.